In one paragraphArticle in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
28 authors.
Anthea CheungMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0009-0000-5969-6215 Neringa PratuseviciuteMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0000-0002-1124-8699 Kirsten BlackMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0009-0006-1356-4560 Pawel LisMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0000-0002-4978-7671 Toan PhungMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0000-0002-2964-6070 Melanie CavinMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0009-0003-5530-7675 Gabriel MorelMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0009-0003-3001-1886 Anna SaariMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.
Vincent HuinUniversity of Lille, Inserm, CHU Lille, U1172 - LilNCog (JPARC) - Lille Neurosciences & Cognition, F-59000 Lille, France.ORCID 0000-0001-8201-5406 Simone Zittel-DirksDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.ORCID 0000-0002-3767-6376 Francesca TonelliMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0000-0002-4600-6630 Benjamin RiebenbauerDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, 72076, Germany.
Thomas GasserDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, 72076, Germany.ORCID 0000-0002-1069-1146 Javier Ruiz-MartinezDepartment of Neurology, Donostia University Hospital, Biogipuzkoa Health Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián ES 20014, Spain.ORCID 0000-0001-7326-6270 Global Parkinson’s Genetics Program (GP2)
Huw R MorrisDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.ORCID 0000-0002-5473-3774 Lara M LangeMolecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, and National Institutes of Health, Bethesda, MD 20892, USA.ORCID 0000-0002-7162-9821 Orly GoldsteinThe Laboratory of Biomarkers and Genomics of Neurodegeneration, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.ORCID 0000-0001-7781-2734 Shachar ShaniThe Laboratory of Biomarkers and Genomics of Neurodegeneration, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
Lionel ArnaudDépartement de Génétique Médicale, APHP Sorbonne Université, Paris 75013, France.
Walter PirkerDepartment of Neurology, Klinik Ottakring, Wiener Gesundheitsverbund, Vienna 1160, Austria.ORCID 0000-0002-9729-9728 Roy AlcalayThe Laboratory of Biomarkers and Genomics of Neurodegeneration, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.ORCID 0000-0002-5717-4875 Katja LohmannInstitute of Neurogenetics, University of Lübeck, Lübeck 23562, Germany.
Dario R AlessiMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0000-0002-2140-9185 Esther SammlerMedical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU), Faculty of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.ORCID 0000-0003-3218-7116 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Pathogenic variants in leucine-rich repeat kinase 2 (
Indexed as
functional annotationkinaseoverexpression assaypathogenicity classificationprotein conservationProtein phosphorylationRab10
Identifiers
PMID42396337
PMCPMC13321175
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390